|
|
|
Volumn 60, Issue 4, 2005, Pages
|
|
Major new initiatives require increased disclosure of clinical trial information
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDEPRESSANT AGENT;
CITALOPRAM;
CYCLOOXYGENASE 2 INHIBITOR;
ESCITALOPRAM;
PAROXETINE;
ROFECOXIB;
ACCESS TO INFORMATION;
CLINICAL RESEARCH;
CLINICAL TRIAL;
DATA BASE;
DRUG EFFECT;
DRUG INDUSTRY;
DRUG INFORMATION;
DRUG LABELING;
DRUG LEGISLATION;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG RESEARCH;
DRUG SAFETY;
DRUG SURVEILLANCE PROGRAM;
DRUG USE;
DRUG WITHDRAWAL;
FUNDING;
GOVERNMENT REGULATION;
HUMAN;
INFORMATION DISSEMINATION;
INFORMATION SERVICE;
INTERPERSONAL COMMUNICATION;
LAW SUIT;
MEDICAL INFORMATION;
POLICY;
PROTECTION;
PUBLICATION;
REVIEW;
SUICIDAL IDEATION;
|
|
EID: 30844466821
PISSN: 1064590X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (3)
|
|
References (0)
|
